PTN
Palatin Technologies, Inc.
There isn't enough reported data to score PTN yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
PTN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
PTN's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
PTN PE Valuation
PTN has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
PTN Forward outlook
There aren't enough analyst estimates for PTN to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
PTN Earnings Per Share
PTN and UNH do not have enough comparable growth data to identify a winner.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
PTN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2024 | $350K | -80% |
| Q4 2023 | $2M | +98% |
| Q2 2023 | $1.8M | +129% |
| Q1 2023 | $1.2M | +453% |
| Q4 2022 | $1M | +311% |
| Q2 2022 | $770.7K | +340% |
| Q1 2022 | $216.1K | +144% |
PTN's revenue is growing: $300,770 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1469% | N/A |
| Q1 2026 | -40% | N/A |
| Q4 2025 | -6316% | N/A |
| Q3 2025 | 53% | N/A |
| Q2 2024 | -2383% | -1770 points |
| Q4 2023 | 58% | +602 points |
| Q3 2023 | -290% | N/A |
| Q2 2023 | -614% | +1086 points |
PTN's operating margin was −1469% last quarter, up 914 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over PTN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over PTN on profitability, with a higher operating margin.
PTN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.7M | +$1.4M |
| Q1 2026 | -$4.5M | +$898.7K |
| Q3 2025 | -$1.6M | +$5.4M |
| Q2 2025 | -$4.1M | +$2.4M |
| Q1 2025 | -$5.4M | +$3.3M |
| Q4 2023 | -$10.5M | +$6.9M |
| Q4 2022 | -$17.4M | -$11M |
| Q3 2022 | -$24.7K | +$6.5M |
UNH has the stronger cash trend. Its trailing FCF is up 5.2% versus its history, compared with PTN at down 23%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
PTN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +54% | +1.4M shares |
| 1 year | +848% | +3.5M shares |
| 3 years | +1789% | +3.7M shares |
| 5 years | +1978% | +3.7M shares |
| Available history | +2262% | +3.7M shares |
PTN has 4M diluted shares, up 848% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over PTN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
PTN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | -2.5x | Net Cash |
| Q4 2019 | -2.5x | Net Cash |
| Q3 2019 | -2.6x | Net Cash |
| Q2 2019 | -1.2x | Net Cash |
PTN has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
PTN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.7 | Neutral |
| Stochastic | 15.1 | Oversold |
PTN's weekly RSI is 38 (neutral) and its Stochastic is 15 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
PTN PE vs Healthcare Sector
PTN has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
PTN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.12 | 7.7% below |
| 20 week MA | $8.79 | 25% below |
| 50 week MA | $14.4 | 54% below |
| 100 week MA | $17.7 | 63% below |
| 200 week MA | $63.0 | 90% below |
PTN is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over PTN on trend strength, trading above more of its moving averages.
PTN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,000.0 | $837.5 | -16% |
| 2021 | $837.5 | $650.0 | -22% |
| 2022 | $650.0 | $118.0 | -82% |
| 2023 | $118.0 | $199.0 | +69% |
| 2024 | $199.0 | $55.5 | -72% |
| 2025 | $55.5 | $14.6 | -74% |
| 2026 YTD | $14.6 | $6.57 | -55% |
PTN has finished lower in five of the last six years. It's down 55% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over PTN on returns for 2026, with the stronger performance.